These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19870010)

  • 1. AN EXAMINATION OF THE MECHANISM OF PNEUMOCOCCUS IMMUNITY BY MEANS OF BACTERICIDAL MEASUREMENTS : II. THE REACTION BETWEEN THE ANTICARBOHYDRATE ANTIBODY AND TYPE-SPECIFIC PRODUCTS OF THE ORGANISM.
    Ward HK
    J Exp Med; 1932 Mar; 55(4):519-30. PubMed ID: 19870010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AN EXAMINATION OF THE MECHANISM OF PNEUMOCOCCUS IMMUNITY BY MEANS OF BACTERICIDAL MEASUREMENTS : I. THE REACTION BETWEEN THE ANTICARBOHYDRATE ANTIBODY AND THE PURIFIED SPECIFIC CARBOHYDRATE.
    Ward HK
    J Exp Med; 1932 Mar; 55(4):511-8. PubMed ID: 19870009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STUDIES ON INFLUENZAL MENINGITIS : II. B. INFLUENZAE-THE PROBLEM OF VIRULENCE AND RESISTANCE.
    Wright J; Ward HK
    J Exp Med; 1932 Jan; 55(2):235-46. PubMed ID: 19869988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AN IMMUNOLOGICAL STUDY OF THE A SUBSTANCE OR ACETYL POLYSACCHARIDE OF PNEUMOCOCCUS TYPE I.
    Enders JF; Wu CJ
    J Exp Med; 1934 Jul; 60(2):127-47. PubMed ID: 19870290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AN ANALYSIS OF THE OPSONIC AND TROPIC ACTION OF NORMAL AND IMMUNE SERA BASED ON EXPERIMENTS WITH THE PNEUMOCOCCUS.
    Ward HK; Enders JF
    J Exp Med; 1933 Mar; 57(4):527-47. PubMed ID: 19870145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FACTORS INVOLVED IN THE PRODUCTION OF IMMUNITY WITH PNEUMOCOCCUS VACCINE : I. ACTIVE AND PASSIVE IMMUNITY DURING THE FIRST SEVEN DAYS AFTER INJECTION OF ANTIGEN.
    Barach AL;
    J Exp Med; 1928 Jun; 48(1):83-104. PubMed ID: 19869473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OBSERVATIONS ON THE PHAGOCYTOSIS OF THE PNEUMOCOCCUS BY HUMAN WHOLE BLOOD : II. THE NEUTRALIZATION OF THE ANTI-PHAGOCYTIC ACTION OF THE SPECIFIC SOLUBLE SUBSTANCE BY ANTISERUM.
    Ward HK
    J Exp Med; 1930 Apr; 51(5):685-702. PubMed ID: 19869720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STUDIES ON PNEUMOCOCCUS GROWTH INHIBITION : VI. THE SPECIFIC EFFECT OF PNEUMOCOCCUS SOLUBLE SUBSTANCE ON THE GROWTH OF PNEUMOCOCCI IN NORMAL SERUM-LEUCOCYTE MIXTURES.
    Sia RH
    J Exp Med; 1926 Apr; 43(5):633-45. PubMed ID: 19869150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A TYPE SPECIFIC SUBSTANCE DISTINCT FROM THE SPECIFIC CARBOHYDRATE IN PNEUMOCOCCUS TYPE I.
    Enders JF
    J Exp Med; 1930 Jul; 52(2):235-52. PubMed ID: 19869762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. THE RELATION BETWEEN THE TYPE SPECIFIC CARBOHYDRATES OF PNEUMOCOCCI AND THE BLOOD GROUP SPECIFIC SUBSTANCE A.
    Witebsky E; Neter E; Sobotka H
    J Exp Med; 1935 Apr; 61(5):703-15. PubMed ID: 19870386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DECOMPOSITION OF THE CAPSULAR POLYSACCHARIDE OF PNEUMOCOCCUS TYPE III BY A BACTERIAL ENZYME.
    Dubos R; Avery OT
    J Exp Med; 1931 Jun; 54(1):51-71. PubMed ID: 19869902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FACTORS INVOLVED IN THE PRODUCTION OF IMMUNITY WITH PNEUMOCOCCUS VACCINE : II. INDUCTION OF ACTIVE IMMUNITY DURING THE COURSE OF LOBAR PNEUMONIA.
    Barach AL;
    J Exp Med; 1931 Mar; 53(4):567-90. PubMed ID: 19869865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ON THE PRESENCE IN ANTIPNEUMOCOCCUS SERUM OF TYPE-SPECIFIC PROTECTIVE ANTIBODY NOT NEUTRALIZED BY HOMOLOGOUS SPECIFIC SOLUBLE SUBSTANCE.
    Sabin AB
    J Exp Med; 1931 Jan; 53(1):93-107. PubMed ID: 19869830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STUDIES ON VIRULENCE : III. INFLUENCE OF HYDROGEN ION CONCENTRATION AND OF INGREDIENTS OF PLAIN BROTH ON THE VIRULENCE OF PNEUMOCOCCI.
    Felton LD; Dougherty KM
    J Exp Med; 1924 Jan; 39(1):155-69. PubMed ID: 19868830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. THE COMPOSITE NATURE OF A PURE CULTURE OF A VIRULENT PNEUMOCOCCUS.
    Amoss HL
    J Exp Med; 1925 Apr; 41(5):649-62. PubMed ID: 19869017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STUDIES ON NATURAL IMMUNITY TO PNEUMOCOCCUS TYPE III : II. CERTAIN DISTINGUISHING PROPERTIES OF TWO STRAINS OF PNEUMOCOCCUS TYPE III VARYING IN THEIR VIRULENCE FOR RABBITS, AND THE REAPPEARANCE OF THESE PROPERTIES FOLLOWING R-->S RECONVERSION OF THEIR RESPECTIVE ROUGH DERIVATIVES.
    Shaffer MF; Enders JF; Wu CJ
    J Exp Med; 1936 Jul; 64(2):281-305. PubMed ID: 19870536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RESULTS OF PROPHYLACTIC INOCULATION AGAINST PNEUMOCOCCUS IN 12,519 MEN.
    Cecil RL; Austin JH
    J Exp Med; 1918 Jul; 28(1):19-41. PubMed ID: 19868242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. THE ROLE OF THE SOLUBLE SPECIFIC SUBSTANCE IN ORAL IMMUNIZATION AGAINST PNEUMOCOCCUS TYPE I.
    Ross V
    J Exp Med; 1931 Nov; 54(6):899-923. PubMed ID: 19869967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. THE MOLECULAR WEIGHT OF ANTIBODIES.
    Heidelberger M; Pedersen KO
    J Exp Med; 1937 Feb; 65(3):393-414. PubMed ID: 19870608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. THE EFFECTS OF ACIDITY UPON THE GROWTH OF PNEUMOCOCCUS IN CULTURE MEDIA CONTAINING PROTEINS.
    Kelley WH
    J Exp Med; 1938 Apr; 67(5):667-74. PubMed ID: 19870747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.